FTC Opens Civil Investigation into Teva Pharmaceuticals Over Asthma and COPD Drug Patents
The US Federal Trade Commission (FTC) has opened a civil investigation into Teva Pharmaceutical Industries Ltd. over its patents for certain drugs, including asthma and COPD inhalers. The investigation focuses on what the FTC describes as 'junk patent listings' and involves about two dozen patents that Teva has refused to remove from a key federal registry. These patents are allegedly improperly listed in an FDA database. The FTC's probe has already impacted Teva's stock, which fell following the news.
Sources
Liz SzaboTeva Pharmaceutical is being investigated by the US Federal Trade Commission over patents for certain drugs including asthma inhalers, according to a person familiar with the matter. https://t.co/F2sh5h7isN via @business
STAT
The FTC is investigating Teva Pharmaceuticals after it refused to remove about two dozen patents for asthma and COPD inhalers from a federal registry. https://t.co/DI5Qimqa4K
pharmalotPharmalot.. Pharmalittle.. Good Morning: We’re reading about FTC probing Teva patents, a Moderna flu vaccine contract & More news.. https://t.co/gyrWwJ0hTc #pharma #Zantac #patents #flu #vaccine $TEVA $PFE $GSK $SNY $NVS $JNJ $APLS $MRNA
Additional media
